Other Names: Butyricimonas virosa Butyricimonas virosa Sakamoto et al. 2009 emend. Hahnke et al. 2016 Butyricimonas virosa Sakamoto et al. 2009 emend. Sakamoto et al. 2014 CCUG 56611 DSM 23226 JCM 15149 Porphyromonadaceae bacterium JCM 15149 strain MT12
Change Display Name to
Source | Percentage | samples |
---|---|---|
SequentiaBiotech | 17.94871794871795 % | 39 |
AmericanGut | 0 % | 18 |
uBiome | 29.73621103117506 % | 834 |
Thryve | 46.276595744680854 % | 376 |
BiomeSight | 56.86274509803921 % | 153 |
I want to know what End Products this bacteria produces
Possible Health Impacts |
I would like to know about this bacteria's
|
If you have multiples samples, there is a time line option, click here, pick your samples and then click [My Taxon Time Line]
Login to see more symptoms with Premium. PValue: a E-9 is stronger association then a E-5 or 0.0001
Medical Condition | Direction | PValue |
---|---|---|
Ankylosing spondylitis | Low | 1 |
Colorectal Cancer | High | 1 |
IgA nephropathy (IgAN) | Low | 1 |
Liver Cirrhosis | Low | 1 |
A P-value below 0.0001 is the recommended threshold. A larger R-Square valye means a stronger relationship. This is unpublished data using Properitary Artificial Intelligence.